The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-((2-((4-(4-Methylpiperazin-1-yl)phenyl)amino)-5-((4-phenoxybenzyl)oxy)pyrimidin-4-yl)amino)phenyl)acrylamide ID: ALA4569421
PubChem CID: 155415496
Max Phase: Preclinical
Molecular Formula: C37H37N7O3
Molecular Weight: 627.75
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1ccc(Oc2ccccc2)cc1
Standard InChI: InChI=1S/C37H37N7O3/c1-3-35(45)40-32-11-7-8-12-33(32)41-36-34(46-26-27-13-19-31(20-14-27)47-30-9-5-4-6-10-30)25-38-37(42-36)39-28-15-17-29(18-16-28)44-23-21-43(2)22-24-44/h3-20,25H,1,21-24,26H2,2H3,(H,40,45)(H2,38,39,41,42)
Standard InChI Key: QBIUISHIKOQSHB-UHFFFAOYSA-N
Molfile:
RDKit 2D
47 52 0 0 0 0 0 0 0 0999 V2000
29.8715 -23.7976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8703 -24.6212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5825 -25.0302 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2963 -24.6208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2934 -23.7940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5807 -23.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1582 -25.0293 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0088 -25.0282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1575 -25.8506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0100 -25.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4452 -26.2612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4442 -27.0817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1563 -27.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8708 -27.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8683 -26.2601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2975 -26.2618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2985 -27.0824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0115 -27.4907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7250 -27.0766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7206 -26.2574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1567 -28.3130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4425 -28.7229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4410 -29.5406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1512 -29.9527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8646 -29.5449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8678 -28.7210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1485 -30.7740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4263 -25.8412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.1401 -26.2504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8499 -25.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5638 -26.2434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1441 -27.0717 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.0037 -23.3786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7171 -23.7886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4233 -23.3732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1351 -23.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8449 -23.3720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8422 -22.5498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1239 -22.1441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4170 -22.5570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5520 -22.1376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.2659 -22.5426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2674 -23.3612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9804 -23.7702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6912 -23.3538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6843 -22.5283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9707 -22.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
4 8 1 0
7 9 1 0
8 10 1 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
10 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 10 1 0
13 21 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
24 27 1 0
20 28 1 0
28 29 1 0
29 30 1 0
30 31 2 0
29 32 2 0
5 33 1 0
33 34 1 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 35 1 0
38 41 1 0
41 42 1 0
42 43 2 0
43 44 1 0
44 45 2 0
45 46 1 0
46 47 2 0
47 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 627.75Molecular Weight (Monoisotopic): 627.2958AlogP: 7.21#Rotatable Bonds: 12Polar Surface Area: 103.88Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.91CX Basic pKa: 7.96CX LogP: 7.22CX LogD: 6.55Aromatic Rings: 5Heavy Atoms: 47QED Weighted: 0.12Np Likeness Score: -1.07
References 1. Du G, Rao S, Gurbani D, Henning NJ, Jiang J, Che J, Yang A, Ficarro SB, Marto JA, Aguirre AJ, Sorger PK, Westover KD, Zhang T, Gray NS.. (2020) Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine., 63 (4): [PMID:31935084 ] [10.1021/acs.jmedchem.9b01502 ]